Facilitate and accelerate the transformation of research results into innovation

From today’s research to tomorrow’s therapies

IRICoR, a Centre of Excellence in Commercialization and Research specialized in drug discovery, has become a key player in the sector both nationally and internationally. IRICoR plays an increasingly pivotal role in the development of novel therapies in cancer and related areas.

The mandate of this not-for-profit organization is to facilitate and accelerate the transformation of research results into innovation for the benefit of patients. IRICoR stands out by the strategic support it provides at all stages of drug development towards commercialization of innovative therapeutic solutions.

 

Located at the Université de Montréal’s (UdeM’s) Institute for Research in Immunology and Cancer (IRIC), IRICoR identifies and funds the most promising national and international projects, supports the research teams throughout the maturation process towards establishing lasting and successful co-development partnerships with industry or creating new spinoff companies.

 

The IRICoR team works closely with investigators and their teams, sharing its expertise in intellectual property, project management and business development – with access to an impressive network of pharmaceutical and financial partners, while contributing to the development of a growing pool of experienced scientific talents in drug discovery and entrepreneurship.

The IRICoR solution to efficiently transform research into innovation also includes privileged access for selected projects to infrastructures and cutting-edge expertise available at IRIC/UdeM, IRICoR’s founding partner. IRIC/UdeM is IRICoR’s founding partner. This expertise includes that of the Drug Discovery Unit of UdeM, which has the largest university-based medicinal chemistry team in Canada previously trained in industry and operating in a university setting.

 

IRICoR is a genuine Quebec-based powerhouse in transformation of research conducted in Quebec, elsewhere in Canada and throughout the world, into highly innovative therapeutic solutions.

 

IRICoR’s Keys Success Factors

  • Embedded in a world-renowned research
    institute with key opinionleaders as principal investigator
  • One of the largest industry-experienced academia-based medicinal groups in Canada
  • Creation of a cultural change  in academia
  • Investing in selected high quality projects
  • Providing industry-standard professionnal project management
  • Implementation of proactive project marketing
  • Establishing strong partnerships with private sector at key development value solides inflexion point

© 2008-2020 IRICoR